Literature DB >> 26617906

Association between Interleukin-10 gene polymorphisms and risk of early-onset preeclampsia.

Limeng Song1, Mei Zhong2.   

Abstract

We conducted a case-control study to investigate the role of IL-10 -1082A/G (rs1800896), -819T/C (rs1800871), and -592A/C (rs1800872) polymorphisms in the development of early-onset preeclampsia. Polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) assay was applied to assess the polymorphisms of IL-10 -1082A/G (rs1800896), -819T/C (rs1800871), and -592A/C (rs1800872). The genotype distributions of IL-10 -1082A/G (rs1800896), -819T/C (rs1800871), and -592A/C (rs1800872) confirmed with HWE in the controls, and the P value for HWE was 0.41, 0.38 and 0.26, respectively. The results of the multivariate logistic regression analysis revealed that the association of individuals expressing the CC genotype and AC+CC of IL-10 -592A/C (rs1800872) with a significantly increased risk of early-onset preeclampsia in co-dominant and dominant models, compared to the AA genotype; the OR (95% CI) for these individuals was determined to be 2.09 (1.12-3.90) and 1.66 (1.03-2.71), respectively. In the recessive model, we found that CC genotype of IL-10 -592A/C (rs1800872) was associated with the increased risk of early-onset preeclampsia when compared with AA+AC genotype (OR = 1.67; 95% CI = 1.01-2.92). In conclusion, our study has indicated that IL-10 -592A/C (rs1800872) polymorphism was associated with an increased risk of early-onset preeclampsia in a Chinese population.

Entities:  

Keywords:  Interleukin-10; early-onset preeclampsia; polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26617906      PMCID: PMC4637722     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  19 in total

1.  Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsia.

Authors:  Jim X Wang; Anne-Margreet Knottnerus; Giny Schuit; Robert J Norman; Annabelle Chan; Gus A Dekker
Journal:  Lancet       Date:  2002-02-23       Impact factor: 79.321

2.  Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia.

Authors:  Sonia T Chelbi; Françoise Mondon; Hélène Jammes; Christophe Buffat; Thérèse-Marie Mignot; Jorg Tost; Florence Busato; Ivo Gut; Régis Rebourcet; Paul Laissue; Vassili Tsatsaris; François Goffinet; Virginie Rigourd; Bruno Carbonne; Françoise Ferré; Daniel Vaiman
Journal:  Hypertension       Date:  2006-11-06       Impact factor: 10.190

Review 3.  The expanding universe of T-cell subsets: Th1, Th2 and more.

Authors:  T R Mosmann; S Sad
Journal:  Immunol Today       Date:  1996-03

Review 4.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

5.  New polymorphisms in the IL-10 promoter region.

Authors:  S D'Alfonso; M Rampi; V Rolando; M Giordano; P Momigliano-Richiardi
Journal:  Genes Immun       Date:  2000-02       Impact factor: 2.676

6.  Interleukin 10 secretion in relation to human IL-10 locus haplotypes.

Authors:  J Eskdale; G Gallagher; C L Verweij; V Keijsers; R G Westendorp; T W Huizinga
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

7.  Cytokine gene polymorphisms in preeclampsia and eclampsia.

Authors:  Telmo H Barbosa de Lima; Nelson Sass; Rosiane Mattar; Antonio F Moron; Maria R Torloni; Camila S Franchim; Silvia Daher
Journal:  Hypertens Res       Date:  2009-05-01       Impact factor: 3.872

8.  Role of IL-10 -819(t/c) promoter polymorphism in preeclampsia.

Authors:  Sabnavis Sowmya; Aruna Ramaiah; Tella Sunitha; Pratibha Nallari; Akka Jyothy; Ananthapur Venkateshwari
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

Review 9.  Cytokine polymorphisms and gastric cancer risk: an evolving view.

Authors:  Barbara G Schneider; M Constanza Camargo; Kelli K Ryckman; Liviu A Sicinschi; M Blanca Piazuelo; Jovanny Zabaleta; Pelayo Correa; Scott M Williams
Journal:  Cancer Biol Ther       Date:  2007-11-05       Impact factor: 4.742

10.  Evaluation of association of maternal IL-10 polymorphisms with risk of preeclampsia by A meta-analysis.

Authors:  Wenchao Yang; Zhenmin Zhu; Jin Wang; Wei Ye; Yong Ding
Journal:  J Cell Mol Med       Date:  2014-09-25       Impact factor: 5.310

View more
  6 in total

1.  Bioinformatics identification of potential genes and pathways in preeclampsia based on functional gene set enrichment analyses.

Authors:  Xue Li; Yanning Fang
Journal:  Exp Ther Med       Date:  2019-07-08       Impact factor: 2.447

Review 2.  The Role of Interleukin-10 in the Pathophysiology of Preeclampsia.

Authors:  Hajrunisa Cubro; Sonu Kashyap; Meryl C Nath; Allan W Ackerman; Vesna D Garovic
Journal:  Curr Hypertens Rep       Date:  2018-04-30       Impact factor: 5.369

Review 3.  Pregnancy, preeclampsia and maternal aging: From epidemiology to functional genomics.

Authors:  Eliza C Miller; Ashley Wilczek; Natalie A Bello; Sarah Tom; Ronald Wapner; Yousin Suh
Journal:  Ageing Res Rev       Date:  2021-12-03       Impact factor: 10.895

4.  Cytokines Interleukin 4 (IL-4) and Interleukin 10 (IL-10) Gene Polymorphisms as Potential Host Susceptibility Factors in Virus-Induced Encephalitis.

Authors:  Ying Yu; Ying Chen; Feng-Ling Wang; Jing Sun; Hai-Jun Li; Jia-Ming Liu
Journal:  Med Sci Monit       Date:  2017-09-22

5.  Optimal Function Prediction of Key Aberrant Genes in Early-onset Preeclampsia Using a Modified Network-based Guilt by Association Method.

Authors:  Jing Wang; Yanping Bi; Junxia Li; Yanfang Tian; Xue Yang; Zhongfang Sun
Journal:  Iran J Public Health       Date:  2018-11       Impact factor: 1.429

Review 6.  Cytokine-polymorphisms associated with Preeclampsia: A review.

Authors:  Carlos Mora-Palazuelos; Mercedes Bermúdez; Maribel Aguilar-Medina; Rosalío Ramos-Payan; Alfredo Ayala-Ham; Jose Geovanni Romero-Quintana
Journal:  Medicine (Baltimore)       Date:  2022-09-30       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.